Literature DB >> 231908

Small cell carcinoma of the lung and its histological origin. Report of a case.

T Hashimoto, M Fukuoka, S Nagasawa, S Tamai, Y Kusunoki, M Kawahara, K Furuse, K Sawamura, T Fujimoto.   

Abstract

A rare lung cancer consisting in part of small cell carcinoma of intermediate cell type and in part of well-differentiated papillotubular adenocarcinoma is described. Alcian blue-PAS staining was observed in the cytoplasm of the small cell carcinoma cells; the Grimelius argyrophil reaction was also positive in the cytoplasm of these cells. Electron microscopy revealed neurosecretory granules in the cytoplasm. At autopsy, a small cell carcinoma of intermediate cell type was found with both squamous features and gland formation. The cellularity and histological pattern of this tumor suggested the existence of a transitional pattern between small cell carcinoma of intermediate cell type, squamous cell carcinoma and adenocarcinoma. From the above findings, we think that small cell carcinoma including the intermediate cell type is derived from respiratory epithelial cells of endodermal origin with dedifferentiation of those cancer cells into neurosecretory cells.

Entities:  

Mesh:

Year:  1979        PMID: 231908     DOI: 10.1097/00000478-197908000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  3 in total

1.  Patients' immune response to breast and lung carcinoma-associated Thomsen-Friedenreich (T) specificity.

Authors:  G F Springer; S M Murthy; P R Desai; W A Fry; H Tegtmeyer; E F Scanlon
Journal:  Klin Wochenschr       Date:  1982-02-01

2.  Tumor heterogeneity in lung cancer based on light microscopic features. A retrospective study of a consecutive series of 200 patients, treated surgically.

Authors:  F R Hirsch; G Ottesen; J Pødenphant; J Olsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

Review 3.  Toward targeting inflammasomes: insights into their regulation and activation.

Authors:  Shelbi Christgen; David E Place; Thirumala-Devi Kanneganti
Journal:  Cell Res       Date:  2020-03-09       Impact factor: 25.617

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.